Instrument Inactif

Autres langues EyeGene Inc. Other OTC

Actions

EYGN.F

KR7185490000

Produits pharmaceutiques

Autres langues

16/09/25	Eyegene Inc to conduct capital increase of 32 billion won for operational funds
21/12/23	EyeGene Inc. announced that it has received KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.
13/12/23	EyeGene Inc. announced that it expects to receive KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.
15/05/23	EyeGene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
15/03/23	EyeGene Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
07/04/22	EyeGene Inc.(KOSDAQ:A185490) dropped from S&P Global BMI Index
04/10/21	Maravai LifeSciences : Says Unit TriLink To Supply Proprietary Technology to EyeGene for Production of COVID-19 Vaccine
20/09/21	EyeGene Inc.(KOSDAQ:A185490) added to S&P Global BMI Index
18/09/20	EyeGene Inc. announced that it has received KRW 22 billion in funding from a group of investors
16/09/20	EyeGene Inc. announced that it expects to receive KRW 22 billion in funding from a group of investors
23/09/19	EyeGene Inc.(KOSDAQ:A185490) dropped from S&P Global BMI Index
28/09/18	EyeGene Inc. announced that it has received KRW 29.9998664 billion in funding from Meritz Securities Co., Ltd., Investment Arm, IBK Capital Corporation, Korea Investment & Securities Co., Ltd., Investment Arm
20/09/18	EyeGene Inc. announced that it expects to receive KRW 29.9998664 billion in funding from a group of investors
15/12/17	EyeGene Inc. announced that it has received KRW 5.4 billion in funding from DSC Investment Inc., G.N.TECH Venture Capital Co., Ltd., Korea Investment Partners Co. Ltd.
14/12/17	EyeGene Inc. announced that it has received KRW 12.6 billion in funding from Korea Investment Partners Co. Ltd., G.N.TECH Venture Capital Co., Ltd., DSC Investment Inc.
12/12/17	EyeGene Inc. announced that it expects to receive funding from Korea Investment Partners Co. Ltd., G.N.TECH Venture Capital Co., Ltd., DSC Investment Inc. and other investors
12/12/17	EyeGene Inc. announced that it expects to receive KRW 5.4 billion in funding from DSC Investment Inc., G.N.TECH Venture Capital Co., Ltd., Korea Investment Partners Co. Ltd.
21/03/16	EyeGene, Inc.(XKON:A185490) added to S&P Global BMI Index
30/12/15	EyeGene, Inc. completed the sale of ICM co., Ltd.
29/12/15	EyeGene, Inc. agreed to sell ICM co., Ltd for KRW 90 million.
04/11/14	LB Investment Inc. through its fund LB Gemini New Growth Fund 16 acquired an unknown stake in EyeGene, Inc. from KoFC-Hanwha Pioneer Champ 2010 Fund 14 and 09-4 Hanwha Venture Investment Partnership, funds of Hanwha Investment Corp for KRW 1.7 billion.